Is this you? Create Your Porfile

D. Olmos Hidalgo

The Royal Marsden NHS Foundation Trust

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where D. Olmos Hidalgo is active.

Explore More

Publication

Featured researches published by D. Olmos Hidalgo.

Annals of Oncology | 2017

LBA32PROREPAIR-B: A prospective cohort study of DNA repair defects in metastatic castration resistant prostate cancer (mCRPC)

E. Castro Marcos; N. Romero Laorden; J.M. Piulats Rodriguez; A. del Pozo; M.I. Sáez; A. Medina Colmenero; Javier Puente; J.C. Silla-Castro; R. Lozano Mejorada; Icíar García-Carbonero; Leonor Rivera; M.J. Méndez Vidal; R. Morales Barrera; E.M. Fernandez Parra; Y. Cendón Flórez; P. Borrega; M.A. Gonzalez Del Alba Baamonde; Colin C. Pritchard; Pablo Lapunzina; D. Olmos Hidalgo

Annals of Oncology | 2017

1660PATM role in prostate cancer (PrCa) progression and survival

Y. Cendón Flórez; P. Nombela Blanco; Antonio Medina; N. Romero Laorden; Javier Puente; P.P. López Casas; A. Gutierrez Pecharromán; R. Sanchez-Escribano; L. Magraner; E. Gallardo Diaz; Nuria Lainez; P. Jiménez Gallego; R. Lozano Mejorada; E. Almagro Casado; R. Luque Caro; Montserrat Domenech; A. Hernández Jorge; E. Castro Marcos; M.D.P. González-Peramato Gutierrez; D. Olmos Hidalgo

Annals of Oncology | 2017

844TiPPROSENZA: Prospective multi-centre study of prognostic factors in castration resistant prostate cancer (CRPC) patients treated with enzalutamide (ENZ)

Antonio Medina; A. Montesa; N. Romero Laorden; Enrique Gonzalez-Billalabeitia; Alejo Rodriguez-Vida; G. Grau; T. Garcés; R. Morales Barrera; F.J. Vazquez Mazon; R. Villatoro; M.A. Gonzalez Del Alba Baamonde; Francisco Javier Perosanz López; S. Hernando Polo; Montserrat Domenech; G. de Velasco; Pablo Borrega; R. Querol; E. Velez; E. Castro Marcos; D. Olmos Hidalgo

Annals of Oncology | 2017

825PLimited value of currently used germline brca mutations predictive tools in prostate cancer

L. Oliva Fernández; M.A. Márquez-Aragonés; N. Romero-Laorden; B.I. Pajares Hachero; Irene Moreno; M. Ruiz Vico; G. Duran Ogaya; C. Muriel; J. Pascual; C. Fernández de Souza; M.E. Dominguez Recio; G. Grau; M.I. Sáez; A. Montesa; R. Correa; D. Olmos Hidalgo

Annals of Oncology | 2017

834TiPRandomized phase III trial of ipatasertib vs. placebo, plus abiraterone and prednisone/prednisolone, in men with asymptomatic or mildly symptomatic previously untreated metastatic castrate-resistant prostate cancer (mCRPC)

J. S. De Bono; Sergio Bracarda; Kim N. Chi; Christophe Massard; D. Olmos Hidalgo; S. Sandhu; C.N. Sternberg; Steven Gendreau; Na Xu; T. Baney; Daniel J. Maslyar; Christopher Sweeney

Annals of Oncology | 2017

843TiPPRORADIUM: Prospective multicentre study of prognostic factors in castration resistant prostate cancer (CRPC) patients treated with radium-223

R. Morales Barrera; M.I. Sáez; Nuria Romero-Laorden; R. Lozano Mejorada; D. Lorente Estelles; G. de Velasco; M.A. Gonzalez Del Alba Baamonde; E. González Billalabeitia; Antonio Medina; P. Borrega García; Alejo Rodriguez-Vida; U. Ferrandiz Brotons; O. Fernandez Calvo; R. García Domínguez; Javier Puente; J.M. Piulats Rodriguez; R. Villatoro; E. Castro Marcos; D. Olmos Hidalgo

Annals of Oncology | 2017

1674PExploratory study of CK-M30 and pHH3 expression in Circulating Tumor Cells (CTCs) as biomarkers of docetaxel (DOC) efficacy in metastatic castration resistant prostate cancer (mCRPC)

P. Nombela Blanco; R. Lozano Mejorada; D. Lorente Estelles; Alison Reid; N. Romero Laorden; G. Attard; Y. Cendón Flórez; Joaquin Mateo; S. Sandhu; Christophe Massard; A. Montesa; Penny Flohr; M.I. Sáez; M.I. Pacheco; E. Castro Marcos; J. S. De Bono; D. Olmos Hidalgo

Annals of Oncology | 2017

826PPrevalence and baseline clinico-pathological associations of germline deleterious mutations in DNA repair genes (gmDDR) in a metastatic castration resistant prostate cancer (mCRPC) prospective spanish cohort (PROREPAIR-B study)

N. Romero Laorden; R. Lozano Mejorada; J.M. Piulats Rodriguez; E. Vallespín; A. Montesa; D. Lorente Estelles; J.C. Villaguzmán; G. Grau; Alejo Rodriguez-Vida; Kristina Ibanez; Enrique Gonzalez-Billalabeitia; L. Magraner; J. Garde; S. Hernando Polo; J. Arranz Arija; R. Villatoro; B. Pérez Valderrama; Pablo Lapunzina; E. Castro Marcos; D. Olmos Hidalgo

Annals of Oncology | 2017

814PLonger time from diagnosis to docetaxel treatment results in a shorter survival in metastatic hormonosensitive prostate cancer (mHSPC) patients treated with chemotherapy+androgen deprivation therapy (ADT)

M.A. Climent Duran; Begoña Mellado; J.M. Piulats Rodriguez; L Heras Lopez; M.J. Juan; M.I. Sáez; Osvaldo A. Reig; A. Montesa; Jaime Suárez; R. Hajianfar; M.J. Ribal; Julio M. Rubio; Matías Castells; R. Villatoro; S. Sandiego; D. Olmos Hidalgo

Annals of Oncology | 2017

800PPhase II study of prednisone-dexamethasone switch in metastatic castration resistant prostate cancer (mCRPC) patients treated with abiraterone and prednisone (AA+P)

R. Lozano Mejorada; N. Romero Laorden; A. Jayaram; Francisco Javier Perosanz López; M.I. Sáez; R. Villatoro; A. Montesa; Irene Moreno; M. Ruiz Vico; M. García Ferrón; J. Rogado; Y. Cendón Flórez; P. Nombela Blanco; Leonor Rivera; G. Grau; J.J. Cruz Hernandez; D. Lorente Estelles; Gerhardt Attard; E. Castro Marcos; D. Olmos Hidalgo

Explore More